loadpatents
name:-0.02465295791626
name:-0.025095224380493
name:-0.0097379684448242
Feher; Miklos Patent Filings

Feher; Miklos

Patent Applications and Registrations

Patent applications and USPTO patent grants for Feher; Miklos.The latest application filed is for "salt and crystal forms of plk-4 inhibitor".

Company Profile
9.28.23
  • Feher; Miklos - New York NY
  • Feher; Miklos - Toronto CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Salt And Crystal Forms Of Plk-4 Inhibitor
App 20210269428 - Sampson; Peter Brent ;   et al.
2021-09-02
Salt and crystal forms of PLK-4 inhibitor
Grant 10,919,886 - Sampson , et al. February 16, 2
2021-02-16
Salt And Crystal Forms Of Plk-4 Inhibitor
App 20200140428 - Sampson; Peter Brent ;   et al.
2020-05-07
Pyrazolopyrimidine compounds
Grant 10,570,143 - Liu , et al. Feb
2020-02-25
Kinase inhibitors and method of treating cancer with same
Grant RE47,731 - Sampson , et al. Nov
2019-11-19
Salt and crystal forms of PLK-4 inhibitor
Grant 10,472,353 - Sampson , et al. Nov
2019-11-12
Salt and crystal forms of PLK-4 inhibitor
Grant 10,392,374 - Sampson , et al. A
2019-08-27
Salt And Crystal Forms Of Plk-4 Inhibitor
App 20190248775 - Sampson; Peter Brent ;   et al.
2019-08-15
Kinase inhibitors and method of treating cancer
Grant 10,358,436 - Sampson , et al.
2019-07-23
Pyrazolopyrimidine Compounds
App 20190040074 - Liu; Yong ;   et al.
2019-02-07
Pyrazolopyrimidine compounds
Grant 10,106,545 - Liu , et al. October 23, 2
2018-10-23
Kinase Inhibitors And Method Of Treating Cancer
App 20180282306 - Sampson; Peter Brent ;   et al.
2018-10-04
Salt And Crystal Forms Of Plk-4 Inhibitor
App 20180155335 - Sampson; Peter Brent ;   et al.
2018-06-07
Kinase inhibitors and method of treating cancer
Grant 9,907,800 - Sampson , et al. March 6, 2
2018-03-06
Salt and crystal forms of PLK-4 inhibitor
Grant 9,884,855 - Sampson , et al. February 6, 2
2018-02-06
Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
Grant RE46,558 - Sherris , et al. September 26, 2
2017-09-26
Pyrazolopyrimidine Compounds
App 20170217966 - Liu; Yong ;   et al.
2017-08-03
Indazole compounds as kinase inhibitors and method of treating cancer with same
Grant 9,580,390 - Pauls , et al. February 28, 2
2017-02-28
Pyrazolopyrimidine compounds
Grant 9,573,954 - Liu , et al. February 21, 2
2017-02-21
Salt And Crystal Forms Of Plk-4 Inhibitor
App 20160264559 - Sampson; Peter Brent ;   et al.
2016-09-15
Methods of targeting PTEN mutant diseases and compositions therefor
Grant 9,402,828 - Pan , et al. August 2, 2
2016-08-02
Kinase Inhibitors And Method Of Treating Cancer
App 20160045511 - Sampson; Peter Brent ;   et al.
2016-02-18
Pyrazolopyrimidine Compounds
App 20150299203 - Liu; Yong ;   et al.
2015-10-22
Kinase inhibitors and method of treating cancer
Grant 9,139,563 - Sampson , et al. September 22, 2
2015-09-22
Methods Of Targeting Pten Mutant Diseases And Compositions Therefor
App 20150182504 - Pan; Guohua ;   et al.
2015-07-02
Kinase inhibitors and method of treating cancer with same
Grant 8,999,968 - Sampson , et al. April 7, 2
2015-04-07
Methods of targeting PTEN mutant diseases and compositions therefor
Grant 8,933,070 - Pan , et al. January 13, 2
2015-01-13
Indazole Compounds As Kinase Inhibitors And Method Of Treating Cancer With Same
App 20140371202 - Pauls; Heinz W. ;   et al.
2014-12-18
Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer
Grant 8,765,748 - Pauls , et al. July 1, 2
2014-07-01
Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer
Grant 8,680,282 - Pauls , et al. March 25, 2
2014-03-25
Kinase Inhibitors And Method Of Treating Cancer With Same
App 20140051679 - Pauls; Heinz W. ;   et al.
2014-02-20
Kinase Inhibitors And Method Of Treating Cancer
App 20140045838 - Sampson; Peter Brent ;   et al.
2014-02-13
Kinase Inhibitors And Method Of Treating Cancer With Same
App 20140045822 - Sampson; Peter Brent ;   et al.
2014-02-13
Kinase inhibitors and method of treating cancer
Grant 8,481,533 - Sampson , et al. July 9, 2
2013-07-09
Kinase inhibitors and method of treating cancer with same
Grant 8,481,525 - Sampson , et al. July 9, 2
2013-07-09
Methods Of Targeting Pten Mutant Diseases And Compositions Therefor
App 20130123273 - Pan; Guohua ;   et al.
2013-05-16
Inhibitors of carnitine palmitoyltransferase and treating cancer
Grant 8,410,150 - Pauls , et al. April 2, 2
2013-04-02
Kinase Inhibitors And Method Of Treating Cancer
App 20120264800 - SAMPSON; Peter Brent ;   et al.
2012-10-18
Kinase inhibitors and method of treating cancer
Grant 8,263,596 - Sampson , et al. September 11, 2
2012-09-11
Kinase Inhibitors And Method Of Treating Cancer With Same
App 20120149686 - Sampson; Peter B. ;   et al.
2012-06-14
Kinase Inhibitors And Method Of Treating Cancer
App 20110263598 - Sampson; Peter B. ;   et al.
2011-10-27
Indazolyl, Benzimidazolyl, Benzotriazolyl Substituted Indolinone Derivatives As Kinase Inhibitors Useful In The Treatment Of Cancer
App 20110065702 - Pauls; Heinz W. ;   et al.
2011-03-17
Cyclic Inhibitors Of Carnitine Palmitoyltransferase And Treating Cancer
App 20110015174 - Pauls; Heinz W. ;   et al.
2011-01-20
Inhibitors Of Carnitine Palmitoyltransferase And Treating Cancer
App 20100105900 - Pauls; Heinz W. ;   et al.
2010-04-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed